Technical420 Site Search

Khiron is capitalizing on strategic medical cannabis markets where several countries have passed legal cannabis legislation. These markets are the European Union (EU) and Latin America (Central and South America). According to Prohibition Partners, the EU and Latin American medical cannabis markets are forecasted to grow at more than 50%…

One of the most exciting aspects of Khiron’s model is related to how it is positioned to disrupt the opioid market in Latin America and the EU. With a combined population of more than 1 billion, we believe these markets represent attractive long-term growth opportunities. Khiron is led by a…

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe , is pleased to announce the appointment of Franziska Katterbach as President, Khiron Europe to replace Tejinder Virk , who…

During the last year, we have seen a substantial increase in the number of studies that are being conducted on cannabis. One of the significant areas of focus for the medical cannabis industry is related to how cannabis can replace opioids and we consider this to be an important topic…

When it comes to the Latin America cannabis market, we consider Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) to be a clear leader. We believe the Latin American cannabis operator is in the early innings of a major growth cycle and is well positioned to capitalize on…

Last week, Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) reported strong first quarter financial results and announced several new company records. From the number of prescriptions filled to the amount of revenue generated, Khiron’s first quarter financial results showed impressive growth on several key metrics and our…

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe , is pleased to announce the receipt of the Company's largest ever shipment of EU-GMP certified medical cannabis product for…

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced today its financial results for the quarter ended March 31, 2021. These filings are available for review on the Company's SEDAR profile at www.sedar.com. All financial information in this press release is…

A few weeks ago, Khiron published fourth quarter financial results and we are favorable on how the business is positioned to record strong growth on a going forward basis.  Reports Ramping Revenues While Cutting Expenses During the quarter, Khiron reported that revenues grew more than 30% on a quarter-over-quarter basis…

Earlier this month, Mexico’s push to legalize recreational cannabis was halted after Senate Majority Leader Ricardo Monreal said that is attempting to extend the Supreme Court’s deadline to change the current law. This development was not well received by the market as Mexico was on the verge of becoming the…